Life-saving percutaneous intervention in young patient with massive pulmonary embolism
Annals of Saudi Medicine. 2012; 32 (4): 433-436
en Inglés
| IMEMR
| ID: emr-132150
ABSTRACT
Massive pulmonary embolism [PE] is not an uncommon condition, and it usually carries a high risk of mortality. It is one of the fatal conditions that commonly affect young patients. A definitive treatment for patients with massive PE is still lacking, and surgical intervention carries a substantial mortality risk. Thus, percutaneous intervention [clot fragmentation and/or aspiration] remains an option in some patients, specifically in those with a risk of bleeding, contraindicating the use of thrombolysis. There have been no randomized trials to validate percutaneous intervention in massive PE. A sufficient level of evidence is still lacking, and its use depends upon the expert committee's opinion and study of previous case reports. We present a 23-year-old man with first onset massive PE secondary to protein C deficiency, who was treated successfully with the combination of systemic thrombolysis and percutaneous interventions:
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Inglés
Revista:
Ann. Saudi Med.
Año:
2012
Similares
MEDLINE
...
LILACS
LIS